Product Information

PREGABALIN 225 MG CAPSULE is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0555 per EA under NDC 65862076490. Its NADAC has been published 124 times since Feb 14, 2024.

PREGABALIN 225 MG CAPSULE

Pregabalin
$0.0555per EA
DEA Schedule CV

Strength

225 mg/1

NDC

65862076490

Classification

Generic

Dosage Form

CAPSULE

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

PREGABALIN

Approval Type

Generic (ANDA)

FDA Application

ANDA205321

On Market Since

3/29/2023

Price Statistics

The NADAC for PREGABALIN 225 MG CAPSULE has been published 124 times since Feb 14, 2024, and over the history we have for it it has declined 32.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0555 per EA
All-time high$0.0857 (Mar 13, 2024)
All-time low$0.0529 (Nov 20, 2024)
52-week high$0.0702
52-week low$0.0555
Median price$0.0667
Average price$0.0661
Largest weekly change-29.0% (Nov 20, 2024)
Weeks tracked124
Tracking sinceFeb 14, 2024

Price History

1W

0.0%

1M

-0.1%

3M

-5.3%

6M

-11.8%

1Y

-18.3%

3Y

N/A

5Y

N/A

All

-32.5%

Generic Alternatives

The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of PREGABALIN 225 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PREGABALIN 225 MG CAPSULE, manufactured by Aurobindo Pharma Limited, is $0.0555 per EA (NDC 65862076490), effective Jun 24, 2026.

How has the price of PREGABALIN 225 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PREGABALIN 225 MG CAPSULE has declined 32.5%. It has been tracked across 124 weekly CMS publications since Feb 14, 2024.

What are the highest and lowest recorded NADAC prices for PREGABALIN 225 MG CAPSULE?

Since Feb 14, 2024, the NADAC for PREGABALIN 225 MG CAPSULE has ranged from a low of $0.0529 (Nov 20, 2024) to a high of $0.0857 (Mar 13, 2024), with a median of $0.0667 per EA.

Are there cheaper alternatives to PREGABALIN 225 MG CAPSULE?

8 NADAC-published products share the same active ingredient, strength, and dosage form as PREGABALIN 225 MG CAPSULE, but none are currently priced below it.

Who manufactures PREGABALIN 225 MG CAPSULE?

PREGABALIN 225 MG CAPSULE (NDC 65862076490) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.